Menopausal hormone therapy (sometimes called hormone replacement therapy, or HRT) uses estrogen, often combined with a hormone called progestin, to ease symptoms like hot flashes, night sweats, and vaginal dryness. It can also help protect against bone loss. Whether it is a good choice for you depends on your age, your health history, and how you weigh the benefits against the risks — which is why every major guideline calls this a decision to make together with a provider, not a one-size-fits-all answer.
Warning Signs That Need Prompt Medical Attention
Most people who use hormone therapy do not have serious problems. But if you are currently using any form of hormone therapy, treat the following as urgent and seek care right away, including calling 911 if symptoms are severe:
- Sudden chest pain, pressure, or shortness of breath.
- Sudden weakness or numbness on one side of the body, trouble speaking, or a sudden severe headache — possible signs of a stroke.
- Swelling, redness, warmth, or pain in one leg, which can signal a blood clot.
- Sudden vision changes.
- New or unexplained vaginal bleeding after menopause, or a big change in bleeding pattern while on hormone therapy — this should be checked by a provider promptly, even if it is not an emergency.
Systemic vs. Local Hormone Therapy: Two Different Tools
Not all hormone therapy works the same way, and the risk profile is not the same for every type. Understanding this distinction is the first step in any conversation with a provider.
Systemic Estrogen Therapy
- Delivered as pills, skin patches, gels, or sprays.
- Estrogen enters the bloodstream and reaches tissues throughout the body.
- Used for widespread symptoms like hot flashes, night sweats, and bone protection.
- If you still have a uterus, a progestin is generally added to reduce the risk of uterine (endometrial) cancer that can occur when estrogen is used alone.
Local (Vaginal) Estrogen Therapy
- Delivered as a vaginal ring, tablet, or cream.
- Used mainly for vaginal dryness, discomfort with sex, and related urinary symptoms.
- Because it is not designed to raise hormone levels throughout the body, it generally carries a different, more limited risk profile than systemic therapy — though it is still a hormone medication and still a decision to make with a provider.
A note on compounded or “bioidentical” hormones: according to the American College of Obstetricians and Gynecologists (ACOG), there is no scientific evidence that compounded hormone preparations are safer or more effective than standard, FDA-approved hormone therapy, and ACOG recommends FDA-approved products instead.
What the Evidence Shows: Potential Benefits
For many people, hormone therapy is the most effective treatment available for:
- Hot flashes and night sweats.
- Vaginal dryness and related discomfort.
- Slowing the bone loss that can lead to osteoporosis and fractures after menopause.
Research has also looked at whether starting hormone therapy relatively soon after menopause, in people without contraindications, changes the balance of heart-related risks compared with starting it many years later — often called the “timing hypothesis.” This is an active area of study, and findings differ by age, health history, and how long therapy is used, so it is not a settled, one-size-fits-all benefit.
What the Evidence Shows: Potential Risks
Hormone therapy is not risk-free, and the risks can depend on the type used, the dose, how long it is taken, and personal health history. Risks that have been studied include:
- An increased risk of blood clots and stroke, particularly with oral (pill) forms of estrogen.
- An increased risk of breast cancer with combined estrogen-plus-progestin therapy when used for several years — this has not been shown the same way for estrogen used alone in people who no longer have a uterus.
- An increased risk of uterine cancer if estrogen is used without progestin in someone who still has a uterus.
In November 2025, the FDA announced it would remove the boxed “black box” warning about these risks from systemic and low-dose vaginal estrogen product labels, saying the change reflected an updated review of the evidence and was meant to reduce a barrier to shared decision-making between patients and clinicians. ACOG’s leadership has said this label change does not mean estrogen products are risk-free — the organization has stated that systemic estrogen still carries risks and that use should be based on an individualized conversation with a clinician, not a blanket recommendation.
Extra-Caution Groups
Hormone therapy is generally not recommended, or needs extra-careful evaluation, for people with certain histories. This list is not complete — it’s a starting point for a conversation, not a substitute for a full medical history review:
- A personal history of breast cancer or certain other hormone-sensitive cancers.
- A history of blood clots, stroke, or heart attack.
- Unexplained vaginal bleeding that hasn’t been evaluated.
- Active liver disease.
- A history of migraine with aura, for some formulations.
- Being pregnant, or a suspected pregnancy.
Only a clinician who knows your full medical history can say whether any of these apply to you and what it means for your options.
A Decision Path for Talking With Your Provider
Use this as a starting checklist before or during an appointment about menopause symptoms:
- Write down your specific symptoms (hot flashes, sleep problems, vaginal dryness, mood changes) and how much they affect daily life.
- List your personal and family health history, including any history of breast cancer, blood clots, stroke, heart disease, or liver disease.
- Ask whether systemic or local therapy fits your main symptoms.
- Ask about your individual risk factors for blood clots, stroke, and breast cancer, based on your history — not just general statistics.
- Ask about non-hormone options if you have contraindications or prefer not to use hormones.
- Ask how you’ll be monitored, and what symptoms should prompt you to call sooner than your next scheduled visit.
- Revisit the decision periodically — your risk profile and goals can change over time.
Evidence Limits
Guidance on hormone therapy has shifted more than once over the past few decades as new research has come out, including a major 2002 study that first raised safety concerns and later research that reexamined those findings by age and time since menopause. This page reflects a general, current summary — not the final word. It doesn’t cover every hormone formulation, dose, or combination, and it isn’t a substitute for guidance based on your own test results and history. Ask your provider what the most current guidance means for your specific situation.
Frequently Asked Questions
Is hormone therapy safe for everyone going through menopause?
No. It is not appropriate for everyone. Whether it’s a reasonable option depends on your age, how long it’s been since menopause, and your personal and family health history. A clinician needs to review your specific situation before making a recommendation.
Does removing the FDA’s black box warning mean hormone therapy has no risks?
No. The FDA’s 2025 label change reflected an updated review of the evidence and was intended to reduce an information barrier, but medical groups including ACOG have said the products still carry risks and that decisions should still be individualized with a clinician.
What’s the difference between systemic and local (vaginal) estrogen therapy?
Systemic therapy (pills, patches, gels, sprays) raises estrogen levels throughout the body and treats widespread symptoms like hot flashes. Local vaginal therapy targets vaginal and urinary symptoms without significantly raising hormone levels elsewhere in the body, and generally has a different risk profile.
Are compounded “bioidentical” hormones a safer alternative?
According to ACOG, there is no scientific evidence that compounded hormone preparations are safer or more effective than standard, FDA-approved hormone therapy. ACOG recommends FDA-approved products.
Related Reading on Reproductive Health Ctr
- Menstrual Cycles & Ovulation — useful background on cycle changes that often show up in the years leading into menopause.
- Reproductive Health & Preventive Care — how routine visits and health screening fit into the years around menopause.
- Read our full Medical Disclaimer.
Educational Disclaimer
This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. It does not recommend hormone therapy, or any specific product, dose, or regimen, for any individual. Reading this page does not create a provider-patient relationship. Whether hormone therapy is appropriate for you depends on your personal health history and should be discussed with a licensed healthcare provider. If you are having a medical emergency, call 911 or go to the nearest emergency room.